Ocular Therapeutix
OCUL
OCUL
64 hedge funds and large institutions have $201M invested in Ocular Therapeutix in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-7
Holders Change %
-9.86%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
9
Increased
21
Reduced
12
Closed
16
Calls
$788K
Puts
$162K
Net Calls
+$626K
Net Calls Change
+$401K
Top Buyers
| 1 |
Jennison Associates
New York
|
+$6.26M |
| 2 |
B
Bailard
Foster City,
California
|
+$2.12M |
| 3 |
CI
Cowen Inc
New York
|
+$1.26M |
| 4 |
D.E. Shaw & Co
New York
|
+$867K |
| 5 |
CCI
Columbus Circle Investors
|
+$827K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.13M |
| 2 |
Millennium Management
New York
|
-$2.6M |
| 3 |
O
OrbiMed
New York
|
-$1.45M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.42M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$898K |
